Ganesh Venkataraman Kaundinya, Senior V.P, Research at MOMENTA PHARMACEUTICALS INC (MNTA), sold 1,069 shares at $15.60 ($17K) on 2017-02-22, disclosed to the SEC on 2017-02-24.
Scheduled sale ($17k) by Senior V.P, Research under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.60 | 231 | $4K | 21.6% |
| 2 | $15.60 | 404 | $6K | 37.8% |
| 3 | $15.60 | 434 | $7K | 40.6% |
| Total | $15.60 avg | 1,069 | $17K | 100% |
| Filing → |
| MNTA | SELL | 2018-08-10 | $18K | — | Filing → |
| MNTA | SELL | 2018-05-23 | $9K | — | Filing → |
| MNTA | SELL | 2018-05-14 | $8K | — | Filing → |